Takeda gets Japan's approval for $62 billion Shire purchase

FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon - RC1702FA7D40/File Photo - Copyright Kim Kyung Hoon(Reuters)

By Reuters

Published on 18/10/2018 - 09:34•Updated 26/04/2024 - 20:35

Comments

(Reuters) - Takeda Pharmaceutical Co Ltd <4502.T> said on Thursday Japan's Fair Trade Commission had approved its $62 billion (£47 billion) acquisition of Shire Plc <SHP.L>, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.

The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States, Brazil and China.

(Reporting by Shashwat Awasthi in Bengaluru)

Comments

You might also like